2017
DOI: 10.3899/jrheum.161480
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies

Abstract: Our study investigates the clinical phenotypes and outcomes of patients with antisynthetase syndrome with distinct antisynthetase antibodies and highlights the link between the anti-PL7 antibody and RP-ILD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
141
4
10

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 145 publications
(175 citation statements)
references
References 39 publications
11
141
4
10
Order By: Relevance
“…Our study could not discover a link between individual anti-ARS antibodies and the long-term clinical course of ILD, in contrast to previous reports on an association between worse prognosis and anti-PL-7 antibody [14, 21]. This is because the lower frequency of PM/DM and the higher frequency of IPAF in our cohort may have led to results different from those of previous studies.…”
Section: Discussioncontrasting
confidence: 56%
“…Our study could not discover a link between individual anti-ARS antibodies and the long-term clinical course of ILD, in contrast to previous reports on an association between worse prognosis and anti-PL-7 antibody [14, 21]. This is because the lower frequency of PM/DM and the higher frequency of IPAF in our cohort may have led to results different from those of previous studies.…”
Section: Discussioncontrasting
confidence: 56%
“…Meanwhile, patients with anti-PL-7, anti-EJ, and anti-Jo-1 autoantibodies would develop myositis later if they only showed ILD at the time of onset. Compared with patients without anti-PL-7, Chinese ASSD patients with anti-PL-7 were more likely to develop rapidly progressive ILD and their survival rate decreased more rapidly at the early stage of long-term follow-up 70 . Furthermore, by analyzing the log-rank test and Cox proportional hazards ratio, researchers demonstrated that non-Jo-1 autoantibody patients had worse survival compared with Jo-1-positive patients 71 .…”
Section: Arss and Autoimmune Diseasesmentioning
confidence: 91%
“…Autoimmune diseases ARSs served as autoantigens in ASSD patients Anti-ARS autoantibody specificity was related to the clinical features, disease severity, and even survival of ASSD patients - [65][66][67][68][69][70][71] HisRS and AsnRS…”
Section: Referencesmentioning
confidence: 99%
“…Though antisynthetase syndrome was not previously considered to be associated with an increased risk of malignancy, a retrospective review of 124 patients with antisynthetase syndrome recently showed a malignancy risk of 6.5%. 4 Overall, the data regarding the association of malignancy and antisynthetase syndrome are confl icting, and this needs further study. Therefore, an age-appropriate malignancy screen is recommended.…”
Section: Association With Cancer Riskmentioning
confidence: 99%